NDC codes

409107 NDC codes with hospital pricing data in the network.

• NDC 51754913101 — MIDAZOLAM (PF) 1 MG/ML IN SODIUM CHLORIDE,ISO-OSM INTRAVENOUS SOLUTION (25 hospitals, 1,335–2,793 samples)
• NDC 76045000320 — Midazolam (24 hospitals, 1,335–2,793 samples)
• NDC 09990340200 — MIDAZOLAM 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS (23 hospitals, 1,335–2,793 samples)
• NDC 76329-3011-05 — LIDOCAINE 2 % MUCOSAL JELLY IN APPLICATOR (78 hospitals, 2,297–2,792 samples)
• NDC 00409525502 — METOCLOPRAMIDE 5 MG/ML INJECTION SOLUTION (34 hospitals, 803–2,792 samples)
• NDC 00409115910 — Sensorcaine 0.25% vial (64 hospitals, 1,611–2,790 samples)
• NDC 71288040302 — 71288-0403-02 - heparin 5000 unit(s) / 1 mL Soln- (242 hospitals, 611–2,789 samples)
• NDC 409909461 — FENTANYL CITRATE (PF) 50 MCG/ML INJ SOLN (122 hospitals, 2,333–2,783 samples)
• NDC 00641-0367-21 — DEXAMETHASONE SODIUM PHOSPHATE 10 MG/ML INJECTION SOLUTION (130 hospitals, 1,999–2,782 samples)
• NDC 00781-3209-90 — CEFTRIAXONE 2 GRAM SOLUTION FOR INJECTION (73 hospitals, 2,114–2,780 samples)
• NDC 409469924 — PROPOFOL 10 MG/ML IV EMUL (85 hospitals, 2,399–2,777 samples)
• NDC 00641-6135-25 — PROCHLORPERAZINE EDISYLATE 10 MG/2 ML (5 MG/ML) INJECTION SOLN (58 hospitals, 1,595–2,774 samples)
• NDC 68084-0318-01 — lamoTRIgine 25mg tab (134 hospitals, 2,501–2,771 samples)
• NDC 409909431 — FENTANYL PER 100MCG (135 hospitals, 2,334–2,766 samples)
• NDC 00093-3426-01 — LORAZEPAM 1 MG TABLET (112 hospitals, 2,474–2,762 samples)
• NDC 00406-0123-01 — HYDROCODONE-ACETAMINOPHEN 5-325 MG ORAL TAB (77 hospitals, 2,474–2,762 samples)
• NDC 00093-3425-01 — LORAZEPAM 0.5 MG ORAL TAB (107 hospitals, 2,474–2,762 samples)
• NDC 43066009025 — PROCHLORPERAZINE EDISYLATE 10 MG/2 ML (5 MG/ML) INJECTION SOLUTION (144 hospitals, 899–2,762 samples)
• NDC 00143932801 — BUPivacaine HCl 0.25% (2.5 mg/mL) Soln 50 mL Vial (98 hospitals, 1,608–2,760 samples)
• NDC 63323054303 — HEPARIN, PORCINE (PF) 5,000 UNIT/0.5 ML INJECTION SOLUTION (65 hospitals, 470–2,756 samples)
• NDC 43547-0543-25 — GLYCOPYRROLATE 0.2 MG/ML INJECTION SUPERORDERABLE (45 hospitals, 2,288–2,756 samples)
• NDC 00409-1273-32 — DIAZEPAM 5 MG/ML INJECTION SYRINGE (227 hospitals, 591–2,751 samples)
• NDC 00143933001 — BUPIVACAINE HCL PRESERVATIVE FREE (PF) INJ 0.25% (97 hospitals, 1,607–2,750 samples)
• NDC 00143933010 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (147 hospitals, 1,607–2,750 samples)
• NDC 00409115909 — BUPivacaine HCl Novaplus (81 hospitals, 1,607–2,750 samples)
• NDC 00409155919 — Marcaine HCl (53 hospitals, 1,607–2,750 samples)
• NDC 00409361311 — BUPivacaine-dextrose-water (PF) 0.75 0.75 (7.5 (109 hospitals, 1,607–2,750 samples)
• NDC 71351002202 — BUPIVACAINE IN DEXTROSE 0.75-8.25 % IT SOLN (98 hospitals, 1,607–2,750 samples)
• NDC 71351002210 — BUPIVACAINE-DEXTROSE-WATER(PF) 0.75 % (7.5 MG/ML) INJ SOLN (116 hospitals, 1,607–2,750 samples)
• NDC 00143932901 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (50 hospitals, 1,607–2,750 samples)
• NDC 00143933401 — BUPivacaine HCl (82 hospitals, 1,607–2,750 samples)
• NDC 00143933301 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (82 hospitals, 1,607–2,750 samples)
• NDC 70594011402 — BUPIVACAINE HCL PRESERVATIVE FREE (PF) INJ 0.25% (67 hospitals, 1,607–2,750 samples)
• NDC 00143932810 — BUPIVACAINE HCL 0.25 % (2.5 MG/ML) INJECTION SOLUTION (100 hospitals, 1,607–2,750 samples)
• NDC 63323046638 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (74 hospitals, 1,607–2,750 samples)
• NDC 71288072532 — BUPivacaine HCl (37 hospitals, 1,607–2,750 samples)
• NDC 09991346500 — BUPIVACAINE 0.125% 750 ML ON-Q CB6004 (SIMPLE) (23 hospitals, 1,607–2,750 samples)
• NDC 09992001222 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (23 hospitals, 1,607–2,750 samples)
• NDC 00409158218 — Marcaine HCl (43 hospitals, 1,607–2,750 samples)
• NDC 09991430567 — BUPIVACAINE 0.125% EPIDURAL (ONE-STEP) (23 hospitals, 1,607–2,750 samples)
• NDC 09991281800 — BUPIVACAINE (PF) 0.125 %(1,250 MCG/ML)IN 0.9% SODIUM CHLORIDE EPIDURAL (23 hospitals, 1,607–2,750 samples)
• NDC 09991281900 — BUPIVACAINE (PF) 0.25 % IN 0.9 % SODIUM CHLORIDE EPIDURAL SOLUTION (23 hospitals, 1,607–2,750 samples)
• NDC 00409-3178-02 — LIDOCAINE 1 %-EPINEPHRINE 1:100,000 INJECTION SOLUTION (118 hospitals, 2,254–2,749 samples)
• NDC 23155052331 — PROCHLORPERAZINE EDISYLATE 10 MG/2 ML (5 MG/ML) INJECTION SOLUTION (83 hospitals, 742–2,749 samples)
• NDC 25021-0052-01 — dexAMETHasone Sodium Phosphate (46 hospitals, 1,713–2,748 samples)
• NDC 63323-0208-05 — LIDOCAINE (PF) 20 MG/ML (2 %) IV SOLN (148 hospitals, 2,375–2,744 samples)
• NDC 23155054741 — 23155-0547-41 - ondansetron 2 mg/mL Soln (141 hospitals, 1,636–2,743 samples)
• NDC 51224002230 — Azithromycin Dihydrate: 30 Tablet, Film Coated In 1 Bottle (51224-022-30) (109 hospitals, 1,456–2,743 samples)
• NDC 00904670806 — AZITHROMYCIN 250 MG PO TABS (103 hospitals, 1,456–2,743 samples)
• NDC 44567-0421-24 — MAGNESIUM SULFATE 4 GM/100ML IV SOLN (34 hospitals, 2,704–2,740 samples)